Hankook Korus Pharm

Hankook Korus Pharm is a South Korean pharmaceutical company and a subsidiary of the GL Rapha group, specializing in the development and manufacture of generic drugs, active pharmaceutical ingredients (APIs), and biological products. The company gained significant international attention as a major contract manufacturer for the Sputnik V COVID-19 vaccine, leading a consortium to produce hundreds of millions of doses for global distribution. It operates multiple manufacturing facilities in South Korea, including sites in Chuncheon and Jecheon, which are equipped for the production of both chemical and biological therapeutics. Hankook Korus is also engaged in the development of biosimilars and long-acting bio-betters using its proprietary PEGylation technology. Its product portfolio includes a wide range of treatments across therapeutic areas such as oncology, endocrinology, and infectious diseases. The company provides comprehensive CDMO services, leveraging its expertise in fermentation and purification of recombinant proteins.